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Orthotopic Liver Transplantation for Hemochromatosis 
P. Pillay, E. Tzoracoleftherakis, A.G. Tzakis, S. Kakizoe, D.H. Van Thiel, and T.E. Starzl 
WE report here the use of orthotopic liver transplan-tation (OL T) at the University of Pittsburgh for the 
treatment of hereditary hemochromatosis (He) in adults. 
An association between iron overload and clinical diabetes 
mellitus. hyperpigmentation and cirrhosis of the liver has 
been recognized since 1871 1; since then. cardiomyopathy 
has been identified as another lethal complication. In 1935. 
Sheldon postulated that this disease. referred to as idio-
pathic hemochromatosis. was an inborn error of iron 
metabolism. 2 With the development of percutaneous liver 
biopsy techniques and the ability to easily measure serum 
iron and ferritin levels. premortem diagnosis became pos-
sible before the development of the lethal hepatic and 
extrahepatic complications. HLA typing has permitted 
discriminating genetic studies of the disease. and the term 
idiopathic hemochromatosis has been replaced with the 
terms primary hemochromatosis or hereditary hemochro-
matosis (He). The availability of these tests has also 
delineated a wide variety of other hepatic disorders (sec-
ondary hemochromatosis or hemosiderosis). J These latter 
conditions include transfusional iron overload in cases 
with thalassemia or hereditary spherocytosis. chronic ex-
cessive iron intake. cirrhosis of any cause associated with 
portal systemic shunting and iron overload. and. particu-
larly. Laennec's (alcoholic) cirrhosis . 
The gene frequency for hereditary hemochromatosis 
(He) is estimated to be I per 200 individuals with 10% of 
the white population thought to carry the gene.4 which is 
on chromosome 6. adjacent to the locus for the HLA 
antigens. H A transferrin saturation index (TSI) of >62% 
can accurately predict 92% of homozygous cases .7 HLA 
antigens A3. 87. and 814 have been shown to be closely 
associated with the gene for He. 4 Five of six of our cases 
were of this variety. The classical complications of diabe-
tes mellitus. bronze pigmentation. arthralgia. pseudogout. 
cardiomyopathy. and cirrhosis often can be forestalled by 
therapeutic phlebotomy if the diagnosis is made early. 
However. once hepatic fibrosis develops. the long-term 
prognosis is poor because of progressive liver failure and 
the frequent development of hepatocellular carcinoma.1I 
MATERIALS AND METHODS 
A total of 14 adult patients were identified who had OLT between 
I January 1982 and J I December 1988 because of hemochroma· 
tosis. Biochemical studies ~ieK serum iron. serum ferritin. trans· 
ferrin saturation index. total iron binding capacity) and histologic 
studies suggested excessive iron overload. The amount of his-
tologic iron deposition was graded on a scale of grade I to IV as 
described by Scheurer et aI.9 Hepatic iron was quantitated by 
atomic absorption spectrometry. Chronic phlebotomy therapy 
had been tried in all cases prior to referral for transplantation. 
Eight of the 14 patients were excluded from further study 
because the foregoing tests. and the clinical histories suggested 
that the iron overload was secondary to either chronic viral 
hepatitis ~O examples). postnecrotic cirrhosis (2). alcoholic cirril<>-
sis (2). or hemolytic disease (2). I n the other 6. the combination of 
clinical data. liver function tests. iron studies of serum and liver. 
HLA typing data. and hepatic histology were consistent with a 
diagnosis of hereditary hemochromatosis. All of these adults had 
prolonged treatment with phlebotomy and/or desferoxamine. 
These six patients were among 1429 liver recipienis treated over 
the 7·year period. They were all males (Table I). Each had classic 
He with a chronic course. Variceal bleeding was the commonest 
symptom while ascites and jaundice were the most frequent signs. 
Two additional infants with perinatal acute hemochromotosis are 
being reponed separately. 
Five of the 6 patients with HC had the H LA antigens associated 
with HC (AJB7). HLA typing was not available for the sixth who 
had diabetes mellitus and clinically significant arthropathy despite 
a number of venesections over a IO-year period (Table I) . The 
mean duration of monthly phlebotomy therapy was 7 years (range 
of 3 to 12 years). One of these six patients had a hepatocellular 
carcinoma. 
RESULTS 
One of the six patients died soon after OLT as the result of 
a hepatic artery thrombosis despite an attempt at retrans-
plantation 19 days after the initi~l OLT. 
The five survivors are well with follow-ups ranging from 
6 months to 5'12 years (Table D. All five have normal liver 
function. Posttransplant biopsies from 6 months to 5 years . 
after transplantation have not shown any evidence of iron 
reaccumulation. 
DISCUSSION 
With He. the excess iron in tissue is distributed widely. 
Iron deposition occurs in the parenchyma of the liver. 
pancreas. other endocrine glands. and heart. Such iron 
deposition leads to cellular injury and the classical clinical 
findings of diabetes mellitus. cardiomyopathy. hyperpig-
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Tlble 1. Clinical Feltures Ind Outcome of PatIents WHh Hemochromatosis 
Age HLA Serum Iron 
(Years) Sex C~nk:al SymptornsiSigns Status SlUdies 
41 M Diabetes. jaundice, variceal A3B7 
bleeding 
44 M Variceal bleeding, jaundice A3B7 
61 M Liver failure, hepatocellular A3B7 
CA 
52 M Diabetes, pigmentation ND' 
45 M Chronic liver failure, en· A3B7 
cephalopathy, varices. 
arthropathy 
44 M Variceal bleeding, ascrtes, A3B7 
liver failure 
'NO g nol done. 
mentation. and hepatic failure. Appropriate therapy con-
sisting of phlebotomy can be effective if instituted early. 
before the development of many of these sequelae. 
The commonest subtype of congenital hemochromato-
~isK hereditary hemochromatosis (HO. is an autosomal 
recessive disorder of iron metabolism with an HLA 
association , ~ All six of our:cases were of this variety and 
all were male. The precise metabolic error in HC is not 
established. An abnormaliiy either in the control of gas-
trointestinal abso'l'tion of iron or hepatic uptake of iron 
are candidate possibilities . 10 An incorrect affinity for iron 
contained in transferrin. II or a defect in the processing of 
iron by the reticuloendothelial system of the liver. I! have 
also been considered. Most of these speculations l ) have 
concerned the adult HLA-linked disorder from which five 
of our six patients suffered. The exact way in which iron 
damages cells also is hypothetical. I) 
Although we have previously mentioned our experience 
of OL T for HC . '4 this is our first formal report on this 
indication for liver replacement. The observations suggest 
that this poorly understood defect in iron metabolism is 
either corrected with liver transplantation or effectively 
palliated for a long period. until enough iron reaccumula-
lion can occur to injure tissues. Even if there is a 
recurrence and. at present. there is no evidence to suspect 
that this should be anticipated. death from causes other 
Grade or Iron Ouralion of FoIlow·Up 
Staining Venesection Outcome Period 
4 7y Alive 4,5 y 
4 12 Y Alive 4.3 y 
4 By Rejection, died 19 days 
after re-GLT 
2 lOy Alive 5y 
4 3y Alive 4 y 
4 6y Alive 0.6 y 
than HC is likely to occur before the latter eventuality is 
reached. Based upon this experience. liver transplantation 
probably will play a larger role in the future in the 
treatment of both classical HC as well as the fulminant 
pediatric disorder. 
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